These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 18497883)
1. Is CD133 a marker of metastatic colon cancer stem cells? LaBarge MA; Bissell MJ J Clin Invest; 2008 Jun; 118(6):2021-4. PubMed ID: 18497883 [TBL] [Abstract][Full Text] [Related]
2. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. Shmelkov SV; Butler JM; Hooper AT; Hormigo A; Kushner J; Milde T; St Clair R; Baljevic M; White I; Jin DK; Chadburn A; Murphy AJ; Valenzuela DM; Gale NW; Thurston G; Yancopoulos GD; D'Angelica M; Kemeny N; Lyden D; Rafii S J Clin Invest; 2008 Jun; 118(6):2111-20. PubMed ID: 18497886 [TBL] [Abstract][Full Text] [Related]
3. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153 [TBL] [Abstract][Full Text] [Related]
5. Quantitative analyses of CD133 expression facilitate researches on tumor stem cells. Liao Y; Hu X; Huang X; He C Biol Pharm Bull; 2010; 33(5):738-42. PubMed ID: 20460748 [TBL] [Abstract][Full Text] [Related]
6. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087 [TBL] [Abstract][Full Text] [Related]
7. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma. Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line. Feng JM; Miao ZH; Jiang Y; Chen Y; Li JX; Tong LJ; Zhang J; Huang YR; Ding J Cancer Biol Ther; 2012 Dec; 13(14):1396-406. PubMed ID: 22954703 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer. Puglisi MA; Sgambato A; Saulnier N; Rafanelli F; Barba M; Boninsegna A; Piscaglia AC; Lauritano C; Novi ML; Barbaro F; Rinninella E; Campanale C; Giuliante F; Nuzzo G; Alfieri S; Doglietto GB; Cittadini A; Gasbarrini A Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():55-62. PubMed ID: 19530513 [TBL] [Abstract][Full Text] [Related]
10. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics. Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735 [TBL] [Abstract][Full Text] [Related]
11. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts. Zhao Y; Zhang W; Guo Z; Ma F; Wu Y; Bai Y; Gong W; Chen Y; Cheng T; Zhi F; Zhang Y; Wang J; Jiang B Oncol Rep; 2013 Oct; 30(4):1782-92. PubMed ID: 23877322 [TBL] [Abstract][Full Text] [Related]
13. Non-invasive in vivo imaging of tumor-associated CD133/prominin. Tsurumi C; Esser N; Firat E; Gaedicke S; Follo M; Behe M; Elsässer-Beile U; Grosu AL; Graeser R; Niedermann G PLoS One; 2010 Dec; 5(12):e15605. PubMed ID: 21187924 [TBL] [Abstract][Full Text] [Related]
14. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis. Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326 [TBL] [Abstract][Full Text] [Related]
15. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848 [TBL] [Abstract][Full Text] [Related]
16. Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells. Cui L; Ohuchida K; Mizumoto K; Moriyama T; Onimaru M; Nakata K; Nabae T; Ueki T; Sato N; Tominaga Y; Tanaka M PLoS One; 2010 Aug; 5(8):e12121. PubMed ID: 20711432 [TBL] [Abstract][Full Text] [Related]
17. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma. Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269 [TBL] [Abstract][Full Text] [Related]
19. CD49f-positive cell population efficiently enriches colon cancer-initiating cells. Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747 [TBL] [Abstract][Full Text] [Related]
20. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function. Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]